The Outcome Health fraud is the story Chicago’s tech scene would rather forget, and the one it most needs to remember. For a few years, Outcome Health was the city’s golden child: a homegrown healthtech company raising money at a valuation most startups only dream about. Then it turned out that much of it was a lie.
The rise
The company, founded in 2006 as ContextMedia, was founded by two Northwestern students, Rishi Shah and Shradha Agarwal. The model sounded smart: install TV screens and tablets in doctors’ offices across the country, then sell that screen time as advertising, mostly to pharmaceutical companies. According to court filings, it raised roughly $487.5 million in debt in 2016, followed by hundreds of millions more in equity in early 2017, drawing in marquee investors like Goldman Sachs and Google’s investment arm. On paper, Chicago had a genuine breakout.
The lie
According to the US Department of Justice, Outcome sold advertising inventory it did not actually have. This led to under-delivery on campaigns while billing clients as if it had been delivered in full. The company inflated its reported revenue for both 2015 and 2016, and those fabricated numbers misled the outside auditor, who signed off on figures that were then used to raise substantial financing. Prosecutors put the scale of the scheme at roughly $1 billion, with some of the proceeds flowing to the founders as dividends.
The reckoning
A jury convicted Shah, Agarwal, and former operating and finance chief Brad Purdy of fraud in April 2023 after a ten-week trial. In June 2024, Shah was sentenced to seven and a half years in prison; Agarwal received three years in a halfway house; and Purdy got two years and three months. A fourth executive who cooperated received a more lenient sentence. The founders have maintained their innocence and said they will appeal.
Why does it still matter
Every boom has a cautionary tale, and this is Chicago’s. The same era that minted real, durable companies also produced one of the largest startup frauds in the country. When capital is flowing freely and everyone is eager for the next unicorn, the incentive to inflate the numbers rises alongside the valuations. That is not a Chicago problem. It is a boom problem. But it is useful to keep it in view as the city’s AI ambitions grow.
I want Chicago to win, but not by pretending this did not happen. The healthy version of a tech hub is one that can produce a $1 billion success and a $1 billion fraud and be honest about both. Outcome Health is a permanent reminder that diligence is not a buzzkill; it is the price of a scene people can actually trust.